APAC IPOs & Placements, Aequitas Research

Kajal Jain

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Anjali Labtech Limited / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/anjali-labtech-limited" target="_blank" data-smartkarma-citation="entities:58778:1" rel="noopener">Anjali Labtech Limited (ANJL IN) </a>(ALL) plans to raise around US$139m in its upcoming India IPO. The deal will be run by Axis and IIFL.</li>
<li>ALL is a leading vertically integrated Indian player in the lab-grown diamond (LGD) industry, as per Wazir report.</li>
<li>As of FY26, it was a leading global MPCVD machine manufacturer for LGD production, with an estimated 36% global volume market share, as per Wazir report.</li>
</ul>



Anjali Labtech Limited (ANJL IN) (ALL) plans to raise around US$139m in its upcoming India IPO. The deal will be run by Axis and IIFL.
ALL is a leading vertically integrated Indian player in the lab-grown diamond (LGD) industry, as per Wazir report.
As of FY26, it was a leading global MPCVD machine manufacturer for LGD production, with an estimated 36% global volume market share, as per Wazir report.


Aequitas: Anjali LabTech Pre-IPO Tearsheet